Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Diagnostic use
- Acronyms RAmP
- Sponsors Avid Radiopharmaceuticals
- 01 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 28 Nov 2016 Status changed from not yet recruiting to recruiting.
- 04 Oct 2016 New trial record